Intervention

Continuous positive airway pressure (CPAP)

ClinicalTrials.gov intervention label

Clinical trials8

Recruiting2

Common conditions19

Lead sponsors shown8

Clinical trials

8 shown

Type 1 Diabetes and Obstructive Sleep ApneaNCT06915831 · 2025-11-10

Obstructive Sleep Apnoea and Difficult Asthma (OSADA)NCT07160868 · 2025-09-01

Screening and Treatment of Obstructive Sleep Apnea in High-risk PregnancyNCT03356106 · 2016-11-16

Evaluation of Continuous Positive Airway Pressure for Tumor Motion Management in RadiotherapyNCT02324530 · 2013-12-01

Sleep, Aging and Risk for Alzheimer's DiseaseNCT01962779 · 2013-07-31

CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients.NCT01771406 · 2013-02-01

Cognitive Benefits of Treating Sleep Apnea in Parkinson's DiseaseNCT00492115 · 2007-07-01

Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS PatientsNCT00409487 · 2006-12-01

Common conditions

Obstructive Sleep Apnea2 Sleep Apnea, Obstructive2 Sleep Disordered Breathing2 "Continuous Positive Airway Pressure"1 Abdominal Tumors1 Alzheimer's Disease1 Asthma (Diagnosis)1 Breast Cancer1 CPAP Treatment1 Endothelial Dysfunction1 Hypertension1 Hypertension,1 Hypertension, Pregnancy-Induced1 Lung Cancer1 OSA - Obstructive Sleep Apnea1 Parkinson's Disease1 Pre-Eclampsia1 Tumor Motion1 Type 1 Diabetes (T1D)1

Leading sponsors

NYU Langone Health1 Ramathibodi Hospital1 Sheba Medical Center1 St. James's Hospital, Ireland1 Universitaire Ziekenhuizen KU Leuven1 University Hospital, Grenoble1 University of California, San Diego1 University of Chicago1

Trial status mix

COMPLETED4

RECRUITING2

UNKNOWN2

Phase mix

NA5

PHASE42

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.